| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/08/2009 | CA2455425C Water soluble extract from plant of solanum genus and the preparation process thereof, and pharmaceutical composition containing the water soluble extract |
| 09/08/2009 | CA2442270C Inhibitors of akt activity |
| 09/08/2009 | CA2442210C Aryl oxime-piperazines useful as ccr5 antagonists |
| 09/08/2009 | CA2440931C Hiv protease inhibitors based on amino acid derivatives |
| 09/08/2009 | CA2434482C Food supplement with a slimming effect |
| 09/08/2009 | CA2431984C Antibiotic coating for porous bodies and method for its production as well as its use |
| 09/08/2009 | CA2417758C Use of the combination of nicotinic acid or derivatives with riboflavin in the manufacture of a medicament for the treatment of primary headaches |
| 09/08/2009 | CA2401160C Biologically active analogs of discodermolide |
| 09/08/2009 | CA2399251C Process for extraction of .beta.-glucan from cereals and products obtained therefrom |
| 09/08/2009 | CA2387351C Indole derivatives as tyrosine kinase inhibitors |
| 09/08/2009 | CA2386770C Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba |
| 09/08/2009 | CA2384422C Method for producing a tablet made of isomaltulose, isomalt or isolmalt variants |
| 09/08/2009 | CA2366820C Novel [(2-substituted-5 -[3-thienyl) -benzyl]-[2- ([2-isopropoxy-5-fluoro] -phenoxy) -ethyl] -amine derivatives, method for the production and use thereof as medicaments |
| 09/08/2009 | CA2360360C Piperidyl benzamide compounds, composition containing same and their use thereof |
| 09/08/2009 | CA2360220C Oxadiazole compounds and compositions for delivering active agents |
| 09/08/2009 | CA2353865C Therapeutic agents for hyperammonemia |
| 09/08/2009 | CA2348319C Cyclohexenol derivative and medicament containing the same |
| 09/08/2009 | CA2342739C Azetidine derivatives, preparation and medicines containing them |
| 09/08/2009 | CA2341010C Process for the manufacture of ethanesulfonyl-piperidine derivatives |
| 09/08/2009 | CA2335623C Aminoiminoquinone and aminoquinine alkaloid compounds as capase inhibitors |
| 09/08/2009 | CA2329636C Riluzole and levodopa combinations for treating parkinson's disease |
| 09/08/2009 | CA2322085C Alcohol-free antibacterial wipes |
| 09/08/2009 | CA2319032C New cytotoxic tris(oxazole)-containing macrolides |
| 09/08/2009 | CA2316388C Tetrahydrobenzindole derivative |
| 09/08/2009 | CA2314339C N-benzyl-3-indenylacetamide derivatives for treating neoplasia |
| 09/08/2009 | CA2312840C The use of polyols in combating yeast infection and polyol preparations for said use |
| 09/08/2009 | CA2295090C 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| 09/08/2009 | CA2293714C Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase |
| 09/08/2009 | CA2292017C Substituted cycloheptenes, their preparation and use |
| 09/08/2009 | CA2290745C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 09/08/2009 | CA2287558C Heterocyclic derivatives and their use as antithrombotic agents |
| 09/08/2009 | CA2286560C Vinca alkaloid antimitotic halogenated derivatives |
| 09/08/2009 | CA2284750C Steroid sulfamates, method for the production and use thereof |
| 09/08/2009 | CA2281955C Ikb kinase, subunits thereof, and methods of using same |
| 09/08/2009 | CA2265276C Modified enantiomer content of crystalline alpha-lipoic acid (rs-thioctic acid) |
| 09/08/2009 | CA2263070C Oral composition |
| 09/08/2009 | CA2253673C 21-substituted progesterone derivatives as new antiprogestational agents |
| 09/08/2009 | CA2252604C Methods of treating type i hypersensitivity using monophosphoryl lipid a |
| 09/08/2009 | CA2242406C Topoisomerase ii poison and bis-dioxypiperazine derivative combination therapy |
| 09/08/2009 | CA2218701C Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 09/08/2009 | CA2213466C Inhibitors of microsomal triglyceride transfer protein and method |
| 09/08/2009 | CA2141731C Antifungal agents, processes for the preparation thereof, and intermediates |
| 09/07/2009 | CA2657526A1 Esters of glucuronide prodrugs of anthracyclines and method of preparation and use in tumor-selective chemotherapy |
| 09/06/2009 | CA2713254A1 Use of ulipristal for treating uterine fibroids |
| 09/06/2009 | CA2657074A1 Compositions for providing an analgesic effect to the skin |
| 09/03/2009 | WO2009108912A1 Protein kinase modulators |
| 09/03/2009 | WO2009108857A2 Combination therapy for prostate cancer |
| 09/03/2009 | WO2009108838A1 Bridged, bicyclic heterocyclic or spiro bicyclic heterocyclic derivatives of pyrazolo[1,5-a]pyrimidines, methods for preparation and uses thereof |
| 09/03/2009 | WO2009108829A2 Crystal forms of 2-{2-[(cyclohexyl)methylene]hydrazino}adenosine |
| 09/03/2009 | WO2009108828A2 Solubility-enhanced forms of aprepitant and pharmaceutical compositions thereof |
| 09/03/2009 | WO2009108824A1 Valsartan solid oral dosage forms and methods of making such formulations |
| 09/03/2009 | WO2009108785A2 Method for treating schizophrenia |
| 09/03/2009 | WO2009108778A1 Sulfonic acid and aldehyde condensation polymers for the treatment and prevention of hpv |
| 09/03/2009 | WO2009108775A2 Process to minimize polymorphism |
| 09/03/2009 | WO2009108766A1 Gamma secretase modulators for the treatment of alzheimer ' s disease |
| 09/03/2009 | WO2009108730A2 Forms of rifaximin and uses thereof |
| 09/03/2009 | WO2009108722A2 Substituted benzoxazinones |
| 09/03/2009 | WO2009108704A1 O-alkylated pi-3 kinase inhibitor prodrug combination |
| 09/03/2009 | WO2009108670A1 Protein kinase inhibitors and use thereof |
| 09/03/2009 | WO2009108657A2 Heteroaryl derivatives as cftr modulators |
| 09/03/2009 | WO2009108635A2 Novel compositions and methods for treatment of diseases related to activated lymphocytes |
| 09/03/2009 | WO2009108573A1 Combination anti-cancer agents |
| 09/03/2009 | WO2009108550A1 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease |
| 09/03/2009 | WO2009108546A1 Ahcy hydrolase inhibitors for treatment of hyper homocysteinemia |
| 09/03/2009 | WO2009108525A2 Hexahydrocyclopentyl[f]indazole carboxamides and derivatives thereof as selective glucocorticoid receptor modulators |
| 09/03/2009 | WO2009108507A1 Therapeutic compounds |
| 09/03/2009 | WO2009108499A1 Tetrahydro-1h-pyrrolo fused pyridones |
| 09/03/2009 | WO2009108497A1 Tetrahydrothieno pyridines |
| 09/03/2009 | WO2009108496A1 Tetrahydrofuropyridones |
| 09/03/2009 | WO2009108407A1 Biodegradable therapeutic nanoparticles containing an antimicrobial agent |
| 09/03/2009 | WO2009108384A2 Compounds and compositions that cause non-apoptotic cell death and uses thereof |
| 09/03/2009 | WO2009108383A2 Substituted xanthine derivatives |
| 09/03/2009 | WO2009108379A1 Novel compositions containing xanthohumol-cyclodextrin complexes |
| 09/03/2009 | WO2009108375A1 Substituted xanthine derivatives |
| 09/03/2009 | WO2009108361A1 Methods for treatment and prevention of breast cancer |
| 09/03/2009 | WO2009108360A2 Inhibition of post-radiation tumor growth |
| 09/03/2009 | WO2009108332A1 INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE TYPE 1 |
| 09/03/2009 | WO2009108274A2 Methods and compositions for adeno-associated virus (aav) with hi loop mutations |
| 09/03/2009 | WO2009108272A1 5-hydroxy-2-methyl-4h-pyran-4-one-esters as novel tyrosinase inhibitors |
| 09/03/2009 | WO2009108255A2 Portable reformed fuel cell systems with water recovery |
| 09/03/2009 | WO2009108118A1 16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use |
| 09/03/2009 | WO2009108117A1 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof 177 |
| 09/03/2009 | WO2009108077A2 Pharmaceutical composition for poorly soluble drugs |
| 09/03/2009 | WO2009108067A2 Prevention and treatment of hsmi |
| 09/03/2009 | WO2009108005A2 Composition and method for screening active material used for the prevention and treatment of diabetes or obesity using senp2 and composition for the prevention and treatment of diabetes or obesity |
| 09/03/2009 | WO2009107959A2 Method for separating valuable flavonoid-containing fraction and novel flavonoid substance from above-ground part of the tree named sageretia theezans |
| 09/03/2009 | WO2009107933A2 Pharmaceutical compositions for inhibiting angiogenesis |
| 09/03/2009 | WO2009107878A1 Vegetable extract containing adenine at high concentration, adenine-containing packed drink containing the vegetable extract, hypotensive composition for oral use containing the vegetable extract as the active ingredient and method of producing the same |
| 09/03/2009 | WO2009107877A1 Pharmaceutical composition |
| 09/03/2009 | WO2009107767A1 Novel bicyclic pyrimidine derivative having antagonistic activity on h4 receptor |
| 09/03/2009 | WO2009107762A1 Aromatic amide derivative |
| 09/03/2009 | WO2009107759A1 Prophylactic or therapeutic agent for ocular disease accompanied by optic nerve disorder |
| 09/03/2009 | WO2009107736A1 Fibrosis inhibitor |
| 09/03/2009 | WO2009107652A1 Agent for enhancing corneal epithelial barrier function |
| 09/03/2009 | WO2009107478A1 Adhesive skin patch and packaged product |
| 09/03/2009 | WO2009107477A1 Medicated patch |
| 09/03/2009 | WO2009107476A1 Medicated patch |
| 09/03/2009 | WO2009107401A1 Kit, composition, product or medicament for treating cognitive impairment |
| 09/03/2009 | WO2009107391A1 Compound having 6-membered aromatic ring |
| 09/03/2009 | WO2009107389A1 Tricyclic compound |